BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22578200)

  • 1. Micro- and macrovascular outcomes in Type 2 diabetic patients treated with insulin glulisine or human regular insulin: a retrospective database analysis.
    Kress S; Kostev K; Dippel FW; Giani G; Rathmann W
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):821-9. PubMed ID: 22578200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower incidence of recorded cardiovascular outcomes in patients with type 2 diabetes using insulin aspart vs. those on human regular insulin: observational evidence from general practices.
    Rathmann W; Kostev K
    Diabetes Obes Metab; 2013 Apr; 15(4):358-63. PubMed ID: 23137345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of macro- and microvascular comorbidity on time to insulin initiation in type 2 diabetes patients: a retrospective database analysis in Germany, France, and UK.
    Kostev K; Rathmann W
    Prim Care Diabetes; 2013 Jul; 7(2):167-71. PubMed ID: 23478140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macro- and microvascular outcomes in patients with type 2 diabetes treated with rapid-acting insulin analogues or human regular insulin: a retrospective database analysis.
    Rathmann W; Schloot NC; Kostev K; Reaney M; Zagar AJ; Haupt A
    Exp Clin Endocrinol Diabetes; 2014 Feb; 122(2):92-9. PubMed ID: 24558019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrovascular and microvascular outcomes after beginning of insulin versus additional oral glucose-lowering therapy in people with type 2 diabetes: an observational study.
    Hall GC; McMahon AD; Carroll D; Home PD
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):305-13. PubMed ID: 22271442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of insulin glulisine on microvascular blood flow and endothelial function in the postprandial state.
    Hohberg C; Forst T; Larbig M; Safinowski M; Diessel S; Hehenwarter S; Weber MM; Schöndorf T; Pfützner A
    Diabetes Care; 2008 May; 31(5):1021-5. PubMed ID: 18268067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
    Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
    Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients.
    Cardoso CR; Salles GF
    J Diabetes Complications; 2008; 22(3):164-70. PubMed ID: 18413219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of basal insulin therapies with regard to the risk of acute myocardial infarction in patients with type 2 diabetes: an observational cohort study.
    Kollhorst B; Behr S; Enders D; Dippel FW; Theobald K; Garbe E
    Diabetes Obes Metab; 2015 Dec; 17(12):1158-65. PubMed ID: 26279482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs.
    Lankisch MR; Ferlinz KC; Leahy JL; Scherbaum WA;
    Diabetes Obes Metab; 2008 Dec; 10(12):1178-85. PubMed ID: 19040645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location.
    Avogaro A; Giorda C; Maggini M; Mannucci E; Raschetti R; Lombardo F; Spila-Alegiani S; Turco S; Velussi M; Ferrannini E;
    Diabetes Care; 2007 May; 30(5):1241-7. PubMed ID: 17290034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment persistence in the use of basal insulins in Poland and Germany
.
    Rathmann W; Czech M; Franek E; Kostev K
    Int J Clin Pharmacol Ther; 2017 Feb; 55(2):119-125. PubMed ID: 27879196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in serum adiponectin concentrations and endothelial function after intensive insulin treatment in people with newly diagnosed type 2 diabetes: a pilot study.
    Li F; Zhao T; Wen X
    Diabetes Res Clin Pract; 2011 Nov; 94(2):186-92. PubMed ID: 21871685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are insulin analogues detemir or glulisine used preferentially in overweight/obese subjects? A German multicentre analysis of 38560 type 2 diabetic patients from the DPV registry.
    Bohn B; Scheuing N; Jehle PM; Laubner K; Born B; Merger S; Hummel M; Krakow D; Voll A; Zimmermann A; Zimny S; Holl RW;
    Exp Clin Endocrinol Diabetes; 2014 Nov; 122(10):602-7. PubMed ID: 25054308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower incidence of macrovascular complications in patients on insulin glargine versus those on basal human insulins: a population-based cohort study in Italy.
    Cammarota S; Bruzzese D; Catapano AL; Citarella A; De Luca L; Manzoli L; Masulli M; Menditto E; Mezzetti A; Riegler S; Putignano D; Tragni E; Novellino E; Riccardi G
    Nutr Metab Cardiovasc Dis; 2014 Jan; 24(1):10-7. PubMed ID: 23806740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
    Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
    Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of preprandial insulin glulisine versus insulin lispro in people with Type 2 diabetes over a 12-h period.
    Luzio S; Peter R; Dunseath GJ; Mustafa L; Owens DR
    Diabetes Res Clin Pract; 2008 Feb; 79(2):269-75. PubMed ID: 18164094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin-inclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study.
    Cheng YY; Leu HB; Chen TJ; Chen CL; Kuo CH; Lee SD; Kao CL
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e99-105. PubMed ID: 24119365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.